These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29333236)

  • 1.
    Jain J; Kumari A; Somvanshi P; Grover A; Pai S; Sunil S
    F1000Res; 2017; 6():1601. PubMed ID: 29333236
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Chaudhary M; Sehgal D
    J Biomol Struct Dyn; 2022; 40(22):11560-11570. PubMed ID: 34355667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico study on anti-Chikungunya virus activity of hesperetin.
    Oo A; Hassandarvish P; Chin SP; Lee VS; Abu Bakar S; Zandi K
    PeerJ; 2016; 4():e2602. PubMed ID: 27812412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential entry inhibitors of the envelope protein (E2) of Chikungunya virus: in silico structural modeling, docking and molecular dynamic studies.
    Deeba F; Malik MZ; Naqvi IH; Haider MSH; Shafat Z; Sinha P; Ishrat R; Ahmed A; Parveen S
    Virusdisease; 2017 Mar; 28(1):39-49. PubMed ID: 28466054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors.
    Ivanova L; Rausalu K; Žusinaite E; Tammiku-Taul J; Merits A; Karelson M
    ACS Omega; 2021 Mar; 6(8):5786-5794. PubMed ID: 33681617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches.
    Nguyen PT; Yu H; Keller PA
    J Mol Graph Model; 2015 Apr; 57():1-8. PubMed ID: 25622129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
    Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
    Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using
    Khan N; Bhat R; Patel AK; Ray P
    J Biomol Struct Dyn; 2021 Mar; 39(4):1373-1385. PubMed ID: 32072865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.
    Utt A; Das PK; Varjak M; Lulla V; Lulla A; Merits A
    J Virol; 2015 Mar; 89(6):3145-62. PubMed ID: 25552719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-Aided Design, Synthesis, and Antiviral Evaluation of Novel Acrylamides as Potential Inhibitors of E3-E2-E1 Glycoproteins Complex from Chikungunya Virus.
    Passos GFS; Gomes MGM; Aquino TM; Araújo-Júnior JX; Souza SJM; Cavalcante JPM; Santos ECD; Bassi ÊJ; Silva-Júnior EFD
    Pharmaceuticals (Basel); 2020 Jun; 13(7):. PubMed ID: 32629969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of silymarin against chikungunya virus.
    Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
    Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the capsid protein of Chikungunya virus in a baculovirus for serodiagnosis of Chikungunya disease.
    Cho B; Kim J; Cho JE; Jeon BY; Park S
    J Virol Methods; 2008 Dec; 154(1-2):154-9. PubMed ID: 18761376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research.
    Kumar S; Mamidi P; Kumar A; Basantray I; Bramha U; Dixit A; Maiti PK; Singh S; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Arch Virol; 2015 Nov; 160(11):2749-61. PubMed ID: 26280524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
    Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
    J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
    Bhakat S; Karubiu W; Jayaprakash V; Soliman ME
    Eur J Med Chem; 2014 Nov; 87():677-702. PubMed ID: 25305334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designed thiazolidines: an arsenal for the inhibition of nsP3 of CHIKV using molecular docking and MD simulations.
    Meena MK; Kumar D; Jayaraj A; Kumar A; Kumari K; Katata-Seru LM; Bahadur I; Kumar V; Sherawat A; Singh P
    J Biomol Struct Dyn; 2022 Mar; 40(4):1607-1616. PubMed ID: 33073705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational approach to study the synthesis of noscapine and potential of stereoisomers against nsP3 protease of CHIKV.
    Singh P; Kumar D; Vishvakarma VK; Yadav P; Jayaraj A; Kumari K
    Heliyon; 2019 Dec; 5(12):e02795. PubMed ID: 32382664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.